Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07812259) titled 'Clinical Tolerance of an Intraparotid Injection of Bupivacaine, Combined With Dexamethasone, After Parotidectomy for Benign Tumor' on Sept. 4.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Centre Hospitalier Universitaire de Nimes
Condition:
Parotid Neoplasm
Bupivacaine
Dexamethasone
Intervention:
Drug: Intraparotid injection of bupivacaine/ dexamethasone
Recruitment Status: Recruiting
Phase: Early Phase 1
Date of First Enrollment: May 18, 2026
Target Sample Size: 10
Countries ...